Evidence map›Paper›PMID 25994218›Full record

ArticleGut2016

Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C.

Thomas Müller, Insha Rasool, Peter Heinz-Erian, Eva Mildenberger, Christian Hülstrunk, Andreas Müller, Laurent Michaud, Bart G P Koot, Antje Ballauff, Julia Vodopiutz and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Gut, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 97 citations in OpenAlex.

  1. Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.Cancer prevention research (Philadelphia, Pa.) · 2017
    Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Zinc inhibits cAMP-induced ClAmerican journal of physiology. Cell physiology · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. New functions and roles of the NaPflugers Archiv : European journal of physiology · 2024
    Review
  16. Calcium-sensing receptor activator cinacalcet for treatment of cyclic nucleotide-mediated secretory diarrheas.Translational research : the journal of laboratory and clinical medicine · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Further delineation of SLC9A3-related congenital sodium diarrhea.Molecular genetics & genomic medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 7 countries.

Thomas MüllerDepartment of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Insha RasoolDepartment of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India.
Peter Heinz-ErianDepartment of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Eva MildenbergerDepartment of Neonatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Christian HülstrunkDepartment of Neonatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Andreas MüllerAbt.Neonatologie (NIPS) Perinatalzentrum, Bonn, Germany.
Laurent MichaudClinique de Pédiatrie, Pôle enfant, Hôpital J de Flandre CHRU de Lille, Inserm U995, Faculté de Médecine, Université de Lille 2, Lille, France.
Bart G P KootDepartment of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands.
Antje BallauffKinderklinik, Helios-Klinikum Krefeld, Krefeld, Germany.
Julia VodopiutzDepartment of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Stefan RosipalPediatric Clinic of Preventive Medicine in Poprad, Slovak Health University, Poprad, Slovakia.
Britt-Sabina PetersenInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, Kiel, Germany.
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, Kiel, Germany.
Irene FuchsDepartment of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Heiko WittPädiatrische Ernährungsmedizin, Else Kröner-Fresenius-Zentrum (EKFZ) für Ernährungsmedizin, Technische Universität München (TUM), Freising-Weihenstephan, Germany.
Heinz ZollerDepartment of Internal Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Andreas R JaneckeDepartment of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Sandhya S VisweswariahDepartment of Neonatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Innsbruck Medical University · ATJohannes Gutenberg University Mainz · DEKiel University · DEAcademic Medical Center · NLElse Kröner-Fresenius-Stiftung · DEHelios Klinikum Krefeld · DEIndian Institute of Science Bangalore · INInserm · FRMedical University of Vienna · ATPerinatal Institute · GBSlovak Medical University · SKUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCongenital sodium diarrhoea (CSD) refers to a form of secretory diarrhoea with intrauterine onset and high faecal losses of sodium without congenital malformations. The molecular basis for CSD remains unknown. We clinically characterised a cohort of infants with CSD and set out to identify disease-causing mutations by genome-wide genetic testing.

designWe performed whole-exome sequencing and chromosomal microarray analyses in 4 unrelated patients, followed by confirmatory Sanger sequencing of the likely disease-causing mutations in patients and in their family members, followed by functional studies.

resultsWe identified novel de novo missense mutations in GUCY2C, the gene encoding receptor guanylate cyclase C (GC-C) in 4 patients with CSD. One patient developed severe, early-onset IBD and chronic arthritis at 4 years of age. GC-C is an intestinal brush border membrane-bound guanylate cyclase, which functions as receptor for guanylin, uroguanylin and Escherichia coli heat-stable enterotoxin. Mutations in GUCY2C were present in different intracellular domains of GC-C, and were activating mutations that enhanced intracellular cyclic guanosine monophosphate accumulation in a ligand-independent and ligand-stimulated manner, following heterologous expression in HEK293T cells.

conclusionsDominant gain-of-function GUCY2C mutations lead to elevated intracellular cyclic guanosine monophosphate levels and could explain the chronic diarrhoea as a result of decreased intestinal sodium and water absorption and increased chloride secretion. Thus, mutations in GUCY2C indicate a role for this receptor in the pathogenesis of sporadic CSD.

Indexed as

Abnormalities, MultipleIntestinal MucosaIntestinesMetabolism, Inborn ErrorsDiarrheaFemaleGenetic Predisposition to DiseaseGuanosine MonophosphateHumansInfantIntestinal AbsorptionMaleMutation, MissenseReceptors, EnterotoxinReceptors, Guanylate Cyclase-CoupledReceptors, PeptideGuanosine MonophosphateGUCY2C protein, humanReceptors, EnterotoxinReceptors, Guanylate Cyclase-CoupledReceptors, PeptideSodiumBACTERIAL ENTEROTOXINSCHRONIC DIARRHOEAGUANYLATE CYCLASEINTESTINAL ION TRANSPORTPAEDIATRIC DIARRHOEA

Identifiers

PMID25994218
PMCPMC4975829
OpenAlexW2166603581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.